At the time of writing, Integra Lifesciences Holdings Corp [IART] stock is trading at $19.23, down -0.21%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IART shares have gain 13.12% over the last week, with a monthly amount glided 8.95%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Integra Lifesciences Holdings Corp [NASDAQ: IART] stock has seen the most recent analyst activity on October 07, 2024, when BTIG Research upgraded its rating to a Neutral. Previously, Citigroup downgraded its rating to Sell on July 30, 2024, and dropped its price target to $23. On July 30, 2024, downgrade downgraded it’s rating to Sell but maintained its price target of $22 on the stock. Wells Fargo downgraded its rating to a Equal Weight and decreased its price target to $25 on May 07, 2024. Oppenheimer downgraded its rating to a Perform. Citigroup upgraded its rating to Neutral for this stock on April 03, 2024, but kept the price target unchanged to $38. In a note dated December 05, 2023, Wells Fargo upgraded an Overweight rating on this stock and boosted its target price from $40 to $49.
For the past year, the stock price of Integra Lifesciences Holdings Corp fluctuated between $16.81 and $45.42. Currently, Wall Street analysts expect the stock to reach $43 within the next 12 months. Integra Lifesciences Holdings Corp [NASDAQ: IART] shares were valued at $19.23 at the most recent close of the market. An investor can expect a potential return of 123.61% based on the average IART price forecast.
Analyzing the IART fundamentals
According to Integra Lifesciences Holdings Corp [NASDAQ:IART], the company’s sales were 1.57B for trailing twelve months, which represents an 9.68% jump. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.01 and Total Capital is 0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.90 points at the first support level, and at 18.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.77, and for the 2nd resistance point, it is at 20.30.
Ratios To Look Out For
It is important to note that Integra Lifesciences Holdings Corp [NASDAQ:IART] has a current ratio of 3.39. Further, the Quick Ratio stands at 2.10, while the Cash Ratio is 0.66. Considering the valuation of this stock, the price to sales ratio is 0.95, the price to book ratio is 0.97 and price to earnings (TTM) ratio is 65.16.
Transactions by insiders
Recent insider trading involved Mosebrook Jeffrey, SVP, Fin & Princ Acct Officer, that happened on Aug 19 ’24 when 1191.0 shares were sold. Exec. Chairman of the Board, ESSIG STUART completed a deal on May 23 ’24 to buy 52641.0 shares. Meanwhile, Director HILL BARBARA B bought 36350.0 shares on May 21 ’24.
